Interestingly, patients with bile duct cancer show multiple alterations at KIR gene loci (46), and genetic variations in KIRs are also present in non-small cell lung cancer patients who are resistant to anti-PD-1 monotherapy (47). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.